“Social media is the canvas on which patients can really paint the entire picture of the experience they’re having with their disease and how it impacts their lives.” – David Williams
Why is it so important for patients and industry to work together? Chief Marketing Officer and Head of Business Development David Williams tells us just that in this week’s installment of “A Look Ahead.” We sat down to discuss the benefits of aligning patient and industry interests as well as the role that social media can play.
Among other win-win results, David shared that this alignment of interests can produce:
- Faster development of treatments and services
- Products that impact a patient’s quality of life, not just clinical outcomes
- Greater patient influence and input on industry decisions
We also talked about how social media has become a key method of interaction, allowing pharmaceutical and other healthcare companies to better understand the functional impact of a disease on everything from mental productivity to the ability to stay employed. Patients like you discuss issues like these online every day, and if the industry is paying attention, it can lead to richer data and improved services.
What successes has PatientsLikeMe had in bringing patients and industry together? And what kind of possibilities do we see ahead? Tune in to David’s full interview here:
Thanks for stopping by and listening to the second podcast in the “A Look Ahead” series. Next Friday, April 1, 2011, we will be talking with Co-Founder and Chairman Jamie Heywood about the transition from drug safety to patient safety. See you then!
- Filed Under: ALS, Chronic Fatigue Syndrome, Conditions, Epilepsy, Fibromyalgia, HIV/AIDS, Mental Health, Multiple Sclerosis, Organ Transplants, Parkinson's Disease, Rare Diseases
- Tags: David Williams, interview, patient and industry interaction, PatientsLikeMeOnCall, podcast
Since 2006, PatientsLikeMe has made great strides in medical research for patients. Of course, all of the research that we do is made possible because of you, our members, and your willingness to openly share your health information, including your treatments, symptoms and outcomes.
PatientsLikeMe-led research has been published in at least six different scientific journals, including the Journal of Medical Internet Research and the Journal of Neurology, Neurosurgery, and Psychiatry. (See our Research page for a full list.) And, if you look us up on Google Scholar, you’ll see that PatientsLikeMe has been cited by others in more than 900 published scientific articles. We’re proud to have made such a noteworthy impact on medical research in five short years.
So what’s next? What can we achieve now that our patient members number more than 97,000? Well, that’s what this podcast episode is all about! Our Director of Research and Development Paul Wicks PhD stopped by PatientsLikeMeOnCall™ to discuss the future of PatientsLikeMe research, some of the challenges we face and the powerful influence patients like you can have when you share your health data.
Tune in to hear Paul’s thoughts here:
Thanks for stopping by and listening to the first podcast in this new series. Next Friday, March 25, 2011, we will be talking with our head of marketing and business development, David S. Williams III, about the importance of patients and industry working together. See you then!
- Filed Under: ALS, Chronic Fatigue Syndrome, Conditions, Epilepsy, Fibromyalgia, HIV/AIDS, Mental Health, Multiple Sclerosis, Organ Transplants, Parkinson's Disease, Rare Diseases, Research
- Tags: A Look Ahead, PatientsLikeMeOnCall, Paul Wicks PhD, podcast